Analysis for Shenzhen Mindray Bio-Medical Electronics
Description & usage
Shenzhen Mindray develops medical devices in patient monitoring, diagnostics, and imaging for hospitals globally. The company benefits from strong innovation, international distribution, and recurring healthcare demand. Key factors are product launches, overseas growth, margin resilience, and regulatory approvals.
Basic info
- Symbol
- 300760.SZ
- Type
- Stock
- Region
- China
- Sector
- Health Care
- Available history
- 7.5 years
- Last trading day
- 04/03/2026
Basic info
- Symbol
- 300760.SZ
- Type
- Stock
- Region
- China
- Sector
- Health Care
- Available history
- 7.5 years
- Last trading day
- 04/03/2026
Market context
- DXY
- 120.89
- US 10Y Real
- 1.99%
- Fed Balance
- $6.68T
- CPI YoY
- 2.4%
- Fed Rate
- 3.75%
- US 10Y
- 4.35%
- VIX
- 24.54
- HY OAS
- 3.17%
- Brent
- $121.88
- Core CPI
- 2.5%
- US 2Y
- 3.84%
- ISM PMI
- –
Score overview
The overall score combines Performance, Stability and Trend into one comparable value.
Market context
- DXY
- 120.89
- US 10Y Real
- 1.99%
- Fed Balance
- $6.68T
- CPI YoY
- 2.4%
- Fed Rate
- 3.75%
- US 10Y
- 4.35%
- VIX
- 24.54
- HY OAS
- 3.17%
- Brent
- $121.88
- Core CPI
- 2.5%
- US 2Y
- 3.84%
- ISM PMI
- –
Analysis summary
Technical asset picture
Shenzhen Mindray Bio-Medical Electronics (300760.SZ) currently has a total score of 15 points, placing it in the very weak range. The score is made up of Performance (6), Stability (35) and Trend (8). All three sub-scores are currently below average.
Performance scores 6 points (very weak). Least weak metric: 1Y return at -35.1 %. Main drag: 3Y return at -51.4 %.
Stability scores 35 points (weak). Key strength: volatility (365d, annualized) at 24.8 %. Main drag: Sortino ratio (90d) at -2.85. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns-but prices can still fall.
Trend scores 8 points (very weak). Trend signals are mostly negative right now. Least weak signal: Price is about 17.3 % below SMA100. Main drag: Price is about 13.0 % below SMA50.
Overall, the picture is very weak: none of the three dimensions shows a clear strength. On a metric level, volatility (365d, annualized) stands out, while Sortino ratio (90d) is the main weak spot.
Current market backdrop
The backdrop currently looks mixed and rather restrictive.
A strong US dollar currently paints a mixed risk picture.
High US real yields and elevated long yields lean toward a restrictive rate backdrop.
What that typically means here
For this asset type, the current backdrop looks mixed rather than clearly directional.
Note: ISM PMI was not used actively in the effect logic.
Historical evaluation and qualitative market context only, not investment advice.
Price chart
Use the chart to read recent price behavior before drilling into metrics.
Scores and metrics
Explore the overall score, the three pillar scores, and the metrics behind them.